U.S. Army has awarded GM Defense LLC a $214.3M production contract to build, field, and sustain...

U.S. Army has awarded GM Defense LLC a $214.3M production contract to build, field, and sustain the Army’s new Infantry Squad Vehicle (ISV).

Photo: GM

The U.S. Army Contracting Command–Detroit Arsenal announced June 27 GM Defense LLC, a subsidiary of General Motors, has been awarded the production contract to build, field, and sustain the Army’s new Infantry Squad Vehicle (ISV). 

Designed to provide rapid ground mobility, the expeditionary ISV is a light and agile all-terrain troop carrier intended to transport a nine-Soldier infantry squad moving throughout the battlefield. The ISV is light enough to be sling loaded from a UH-60 Blackhawk helicopter and compact enough to fit inside a CH-47 Chinook helicopter for air transportability. The total production ISV contract award value is $214.3 million to procure the initial Army Procurement Objective of 649. The approved Army Acquisition Objective is 2,065 vehicles.

The ISV is based off the 2020 Chevrolet Colorado ZR2 midsize truck architecture and leverages 90% commercial off-the-shelf parts. These parts include the Multimatic dual spool-valve dampers and Chevrolet Performance suspension components.

All ISV models will be equipped with an occupant and cargo superstructure powered by a 186-horsepower, 2.8L Duramax turbo-diesel engine, and six-speed automatic transmission.

In 2019, GM Defense partnered with Ricardo Defense after the U.S. Army awarded three $1 million contracts to competing industry providers to develop ISV prototypes for testing, evaluation, and down-selection for the production contract. Ricardo Defense will support key product logistics and fielding requirements of the GM Defense ISV.

About the author
Staff Writer

Staff Writer

Editorial

Our team of enterprising editors brings years of experience covering the fleet industry. We offer a deep understanding of trends and the ever-evolving landscapes we cover in fleet, trucking, and transportation.  

View Bio
0 Comments